Celyad Sa ADR (CYAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYAD | AMGN | VRTX | REGN | BMY |
| Company | Celyad Sa ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.5200 | 335.15 | 474.36 | 1,145.99 | 49.29 |
| High | 0.5280 | 338.97 | 474.93 | 1,149.42 | 49.53 |
| Low | 0.4700 | 334.27 | 463.81 | 1,136.22 | 49.00 |
| Last | 0.4700 | 337.38 | 464.92 | 1,145.03 | 49.41 |
| Change | -0.0587 | +1.43 | -12.98 | -5.16 | +0.39 |
| % Change | -11.10% | +0.43% | -2.72% | -0.45% | +0.80% |
| Volume | 49,000 | 4,068,200 | 2,238,700 | 913,900 | 27,106,500 |
| 20-Day Average Volume | 17,230 | 1,855,500 | 1,043,350 | 450,570 | 9,468,160 |
| Previous Close | 0.5287 | 335.95 | 477.90 | 1,150.19 | 49.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6235 | 330.23 | 479.12 | 1,163.38 | 49.18 |
| 20-Day Raw Stochastic | 0.00% | 91.90% | 10.69% | 32.45% | 60.24% |
| 20-Day Relative Strength | 35.64% | 58.76% | 43.24% | 51.59% | 55.67% |
| Weighted Alpha | -88.73 | +27.84 | +28.48 | +40.25 | -10.22 |
| Today's Opinion | 100% Sell | 100% Buy | 24% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 96% Buy | 40% Buy | 80% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 88% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.58% since 05/11/23 | +1.48% since 09/13/24 | -4.21% since 09/13/24 | -0.72% since 09/13/24 | +0.57% since 09/13/24 |
| Low | 0.4700 on 05/18/23 | 331.00 on 09/18/24 | 463.81 on 09/20/24 | 1,134.59 on 09/17/24 | 48.78 on 09/18/24 |
| High | 0.6500 on 05/12/23 | 339.00 on 09/18/24 | 490.15 on 09/16/24 | 1,165.85 on 09/19/24 | 50.41 on 09/17/24 |
| 1-Month | |||||
| %Chg | -41.43% since 04/18/23 | +2.69% since 08/20/24 | -4.61% since 08/20/24 | -3.96% since 08/20/24 | +0.88% since 08/20/24 |
| Low | 0.4700 on 05/18/23 | 319.00 on 09/06/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 | 46.88 on 08/22/24 |
| High | 0.8200 on 04/19/23 | 339.00 on 09/18/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 | 50.75 on 09/04/24 |
| 3-Month | |||||
| %Chg | -61.48% since 02/17/23 | +8.87% since 06/20/24 | -1.37% since 06/20/24 | +9.64% since 06/20/24 | +20.39% since 06/20/24 |
| Low | 0.4700 on 05/18/23 | 306.11 on 07/03/24 | 458.04 on 08/13/24 | 1,011.67 on 07/03/24 | 39.35 on 07/05/24 |
| High | 1.2800 on 02/21/23 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -55.26% since 11/18/22 | +23.56% since 03/20/24 | +12.81% since 03/20/24 | +18.42% since 03/20/24 | -4.76% since 03/20/24 |
| Low | 0.4604 on 12/30/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 3.0700 on 01/18/23 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.47 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,619 | 180,215,344 | 123,323,528 | 126,734,816 | 99,368,440 |
| Shares Outstanding, K | 22,594 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 110,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -9,140,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 12,201,000,000 |
| Last Quarter Net Income | -6,483,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,680,000,000 |
| 60-Month Beta | 1.86 | 0.61 | 0.40 | 0.12 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 03/28/24 | 10/29/24 | 11/04/24 | 11/07/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 0.00 | 29.64 | 36.31 |